SCHEMBL6979824

SCHEMBL6979824

CC(=O)Nc1nc(NC(C)=O)nc(C2CCC(c3ccccc3)CC2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.48
ADORA1 P30542 1/20 0.48
SCN9A Q15858 2/20 0.44
POLB P06746 1/20 0.42
DEGS1 O15121 1/20 0.42
SLC18A3 Q16572 1/20 0.41
AKR1C3 P42330 1/20 0.41
AKR1C1 Q04828 1/20 0.41
GAA P10253 1/20 0.40
HDAC4 P56524 1/20 0.40
PCSK9 Q8NBP7 1/20 0.40
BRAF P15056 1/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 1/20 0.40
HSD17B10 Q99714 2/20 0.40
NAPRT Q6XQN6 1/20 0.40
ALDH1A1 P00352 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983221 0.91 SCN9A (0.43) ADORA3ADORA1SCN9APOLBDEGS1
SCHEMBL18869949 0.71 NPY5R (0.56) AKR1C3AKR1C1SMN1; SMN2ALDH1A1ALOX15
Bicarbonate SCHEMBL7573346 0.71 AKR1C3 (0.63) DEGS1SLC18A3AKR1C3AKR1C1GAA
Bicarbonate SCHEMBL1720488 0.71 AKR1C3 (0.63) DEGS1SLC18A3AKR1C3AKR1C1GAA
Methyl Alcohol SCHEMBL2329914 0.69 SLC18A3 (0.58) SLC18A3AKR1C3AKR1C1NPC1RAB9A
SCHEMBL1836974 0.69 AKR1C3 (0.61) POLBDEGS1SLC18A3AKR1C3AKR1C1
SCHEMBL2448396 0.69 AKR1C3 (0.61) POLBDEGS1SLC18A3AKR1C3AKR1C1
Hydrogen Peroxide SCHEMBL2353767 0.69 SLC18A3 (0.64) SLC18A3AKR1C3AKR1C1NPC1RAB9A
SCHEMBL5868999 0.69 SLC18A3 (0.63) POLBSLC18A3NPC1RAB9ASMN1; SMN2
SCHEMBL3299561 0.69 POLB (0.62) ADORA3ADORA1POLBRAB9AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP claimed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US claimed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP claimed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed